Experimental drug ADCT-301 tested in just 3 patients for relapsed blood cancers
Disease control
Terminated
This study tested a drug called ADCT-301 in 3 adults whose acute myeloid leukemia, myelodysplastic syndrome, or related blood cancer came back after a stem cell transplant. The goal was to see if the drug is safe and can help patients achieve remission. The study was stopped earl…
Phase: PHASE2 • Sponsor: Gwynn Long, M.D. • Aim: Disease control
Last updated May 17, 2026 09:08 UTC